Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TransMedics Gr Q3 EPS $0.66 Beats $0.35 Estimate, Sales $143.823M Miss $145.256M Estimate

Author: Benzinga Newsdesk | October 29, 2025 03:06pm
TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.35 by 88.57 percent. This is a 450 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $143.823 million which missed the analyst consensus estimate of $145.256 million by 0.99 percent. This is a 32.24 percent increase over sales of $108.761 million the same period last year.

Posted In: TMDX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist